With the FDA decision on Biogen's Aducanumab | IONS Message Board Posts


Ionis Pharmaceuticals, Inc.

  IONS website


  • We have set up a new board (#AdminHowTo) to better assist you with using our service and getting the most out of it.

    To access the board, click the blue link above or, if you are a registered member, you can check the latest message from Admin in your IV Inbox and click the link provided there as well.  

IONS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  61601 of 61685  at  6/15/2021 3:43:32 AM  by

Bigbiotechbull


 In response to msg 61600 by  aaljack
view thread

Re: With the FDA decision on Biogen's Aducanumab

The Phase 2 showed knockdown of the target but only slight clinical benefit, and any clinical benefit may have been a mirage due to the small sample size.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
61602 Re: With the FDA decision on Biogen's Aducanumab aaljack 0 6/15/2021 3:40:43 PM


Financial Market Data provided by
.
Loading...